Group Companies Commend 2017 Advanced
Release time:
2020-08-14
Group Company Commends 2017 Advanced
News 1# September 28 Afternoon, Group Company Held 2017 Summary Commendation Conference. While reviewing the work of the previous year and making arrangements for the work of 2018 , ceremoniously commend 2017 advanced collectives and individuals, and sign 2018 economic responsibility system with professional companies and directly affiliated enterprises. Yu Jianhong, general manager of
Group Company, made a work report entitled "creating a new situation, creating new advantages; embarking on a new journey and realizing new brilliance" at the conference. 2017 , according to the company's five-year development plan, all enterprises carried out various operation and management work in an orderly manner around the general policy of "grasping the trend, accurate development, strengthening standards, improving quality, improving management and enhancing efficiency", and achieved unprecedented business performance. Yu Jianhong started from focusing on the company's strategic planning, looking for new opportunities and achieving new results; in-depth management integration and continuous improvement of management level; technological innovation and technological transformation have achieved significant results; strengthening marketing management and market expansion; team building and talent training have made progress; standardize Safety management system, promote the establishment of safety and environmental protection accident-free factories; actively support party, labor, league and volunteer activities, and strengthen corporate culture construction; in eight aspects, such as the effective promotion of corporate image and influence, a comprehensive summary and review of the work of 2017 was made.
2018 is the 32nd anniversary of peak start-up 60. After a comprehensive analysis of the current national economic situation, policies and the changing trends of the company's related industries, Yu Jianhong, according to the company's five-year development plan and the three-year operation plan of various industrial sectors, put forward the working policy of 2018 as follows: determined to change, deepen management and promote all-round high-quality development of the enterprise. Focusing on this policy, the key tasks in 2018 are: formulating new plans, promoting new development, and creating new profit growth points; continue to promote information construction and move towards intelligent manufacturing; strengthen management responsibilities, promote management innovation, and comprehensively Improve management capabilities; strengthen technological innovation and improve the development system; further strengthen marketing management and comprehensively improve marketing capabilities; further attach importance to human resource management and strengthen the construction of talent teams; establish a new concept of safety management, promote safety and environmental protection management to a higher level; further strengthen the construction of corporate culture, and add impetus to the realization of the corporate vision of "one hundred years peak. At the
2018 economic responsibility system with daye peak, Yunnan peak, pharmaceutical company, health technology company, international trading company and cable company. Xiang Chongping, deputy general manager of
2017 Group Company at the conference. In the warm atmosphere, the company's advanced red hanging lottery on stage to receive the award. Zheng Kunwu, representative of advanced enterprises and director of Jinxi Pharmaceutical Factory of Jianfeng Pharmaceutical Company, Fang Xuhua, representative of advanced party organization and party branch secretary of Yunnan Jianfeng Cement Company, representative of innovation experts and Sun Huageng of Tianjin Jianfeng Natural Products Company, representative of outstanding employees and Yang Zhendong of Daye Jianfeng Cement Company, representative of outstanding salesmen and Wang Xiuling of Xinhua Pharmacy of Jianfeng Pharmacy took the stage to speak respectively, reviewing the past year's work gains and losses and sharing experiences. At the end of the
60. (Details are published separately) (Reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31